LSU Health Sciences Center, Feist-Weiller Cancer Center

Shreveport, Louisiana 71130

0 studies enrolling now · 11 studies all time

What they study most

AML, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Cutaneous T-cell Lymphoma (CTCL),, Giant Cell Glioblastoma, Glioblastoma, Glioblastoma With Oligodendroglial Component, Gliosarcoma, Hemoglobin S Disease, Leukemia, B-Cell, Chronic, Non-Hodgkin's Lymphoma, Pancreatic Adenocarcinoma

Studies at this site

• Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine Alone in Previously Untreated Patients With Pancreatic Adenocarcinoma — Completed
• (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive — Completed
• A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia — Completed
• Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia — Completed
• Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia — Stopped early
• Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma — Completed
• Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab — Completed
• Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma — Completed
• A Study of HQK-1001 in Patients With Sickle Cell Disease — Completed
• Forodesine in the Treatment of Cutaneous T-Cell Lymphoma — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed